Recommended Free Tools
Ascend Laboratories, the U.S. distributor of a generic atorvastatin product made by India-based Alkem Laboratories, announced a recall after sample tablets reportedly failed dissolution testing. The concern is that tablets that do not dissolve properly may release less medicine for absorption. The reported recall applies to a specific product and affected lots—not to all generic atorvastatin or all medicines made in India.
What was recalled, and why?
The product at issue is generic atorvastatin distributed by Ascend Laboratories and manufactured by Alkem Laboratories. Atorvastatin is a prescription medicine used to lower cholesterol and reduce cardiovascular risk. A tablet must dissolve so its active ingredient can be absorbed; a dissolution failure could mean that a patient receives less medicine than intended and that treatment is less effective.
C Michael White’s Nov. 4, 2025 article in The Conversation, republished by Scroll.in, reports that Ascend announced the recall on Sept. 19, 2025, after sample tablets failed dissolution testing. White reports that the recall covered about 142,000 bottles containing 90, 500 or 1,000 tablets, with affected tablets manufactured between November 2024 and September 2025. These are article-reported figures; check the FDA’s current record for the exact affected products and lots.
Why did the distributor issue the recall?
A drug’s path from a factory to a patient involves distinct companies and responsibilities. Alkem Laboratories manufactured the tablets; Ascend Laboratories distributed the product in the United States and is identified as the recalling firm. A distributor can initiate a recall of a product it distributes even when another company manufactured it. That distinction does not, by itself, establish fault beyond the reported quality defect.
#1 Best Overall
The FDA classified the recall as Class II on Oct. 10, 2025, according to White’s article. FDA uses this category when use of, or exposure to, a product may cause temporary or medically reversible adverse health consequences. The classification is not a statement that every bottle caused harm, nor does it mean every lot of atorvastatin is affected. Recall details and status can change, so consult the FDA’s current information rather than relying on an old lot list.
How to check whether your prescription is affected
- Check the prescription label. Look for Ascend as the labeler or manufacturer information such as “MFG” or “MFR.” The label may not give enough information to identify the affected lot by itself.
- Call the pharmacy that filled it. Ask the pharmacist to use your prescription number to identify the product and lot number dispensed.
- Compare the lot with the FDA’s current recall information. Use the FDA recall information page or ask the pharmacist to confirm whether the lot is included and whether the recall status has changed.
- Ask what to do with the tablets. If your lot is affected, follow the pharmacist’s or prescriber’s instructions about replacement and disposal.
What should you do if you take this medicine?
Do not stop or change your atorvastatin on your own. Contact your pharmacist or prescriber promptly to check the product and arrange advice about continuing treatment or obtaining a replacement. Stopping a cholesterol medicine without a plan may interrupt prescribed care; the recall notice is a reason to verify your supply, not a reason to make an unsupervised medication change.
Rank #2
If you believe you experienced a problem with a medicine, consumers and patients can submit a voluntary report through FDA MedWatch, online or using Form FDA 3500B. A report does not confirm that a product was recalled and does not replace checking the lot or speaking with a pharmacist or prescriber.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What this recall does—and does not—say about Indian-made medicines
White’s article notes a separate 2023 recall involving 58,000 bottles of Alkem metoprolol XL. That earlier event is context, not the same recall: it involved a different medicine and should not be conflated with the atorvastatin action. Neither event alone establishes that all products made in India are unsafe. The practical question for a patient is whether their specific product and lot are included in the current recall information.
Free tools Windows power users keep installed
One-click scans. No signup required.
Quick Recap
Rank #4
Rank #3
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
